The University of Chicago Header Logo

Connection

Ezra Cohen to Treatment Adherence and Compliance

Back to Details
This is a "connection" page, showing publications Ezra Cohen has written about Treatment Adherence and Compliance.
Ezra Cohen
Connection Strength
0.043
Treatment Adherence and Compliance
  1. Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial. Oral Oncol. 2019 10; 97:82-91.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.